![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
Abstract
The use of botulinum toxin A is a relatively new and innovative therapeutic intervention for children with cerebral palsy. The purpose of this review is to summarize nine articles, all published since 1993, that relate specifically to the use of botulinum toxin A in the management of spasticity in children with cerebral palsy. A range of outcome measures were employed in these studies including assessment of muscle tone, range of motion, appearance, gait analysis, gross or fine motor functional status, and parent or guardian questionnaire. In general, the findings demonstrated significant improvements, especially in muscle tone, range of motion, and functional motor status.
Additional information
Notes on contributors
Marie I. Shaw
Michael Lepp, PT, is in private practice, Associate Instructor of the Upledger Institute, and Clinical Instructor, Case Western Reserve University School of Dentistry, Cleveland, OH.
Marie McKenzie, MS, OTR, is in private practice. She was Coordinator of Occupational Therapy at Scottish Rite Hospital at the time of this study.
Heather Miller, MS, OTR/L, is currently employed by Madison County Educational Service Center, providing therapy services to the county's pre-schools. This research was completed in partial fulfillment of the requirements of an MS degree at Ohio State University.